KFin Technologies Limited (BOM:543720)

Inozyme Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 6, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	184,780	177,177	104,927	47,426	-	-
Market Cap Growth	93.45%	68.86%	121.24%	-	-	-
Enterprise Value	178,935	173,451	103,083	47,316	-	-
Last Close Price	1073.60	1029.95	608.83	278.32	-	-
PE Ratio	54.06	53.27	42.65	24.23	-	-
PS Ratio	15.83	15.70	12.19	6.50	-	-
PB Ratio	13.13	12.59	9.20	5.45	-	-
P/TBV Ratio	26.95	25.84	24.20	22.99	-	-
P/FCF Ratio	-	49.55	40.15	23.76	-	-
P/OCF Ratio	-	44.42	36.28	21.23	-	-
EV/Sales Ratio	15.33	15.37	11.98	6.48	-	-
EV/EBITDA Ratio	33.16	33.57	28.45	16.64	-	-
EV/EBIT Ratio	38.46	38.35	30.54	18.11	-	-
EV/FCF Ratio	-	48.51	39.44	23.71	-	-
Debt / Equity Ratio	0.03	0.03	0.04	0.18	0.25	1.10
Debt / EBITDA Ratio	0.09	0.09	0.13	0.54	0.56	1.80
Debt / FCF Ratio	-	0.13	0.19	0.80	0.69	1.92
Asset Turnover	-	0.71	0.65	0.64	0.66	0.54
Inventory Turnover	-	-	170.64	124.18	97.99	95.62
Quick Ratio	-	4.82	4.89	1.91	2.56	1.94
Current Ratio	-	5.23	5.14	2.04	2.75	2.02
Return on Equity (ROE)	-	26.10%	24.47%	25.85%	29.99%	-17.07%
Return on Assets (ROA)	-	17.84%	15.80%	14.34%	16.42%	12.94%
Return on Capital (ROIC)	22.01%	21.38%	19.00%	17.81%	20.88%	14.93%
Return on Capital Employed (ROCE)	-	28.60%	25.90%	25.70%	27.70%	23.20%
Earnings Yield	1.85%	1.88%	2.34%	4.13%	-	-
FCF Yield	-	2.02%	2.49%	4.21%	-	-
Dividend Yield	0.69%	0.73%	0.94%	-	-	-
Payout Ratio	37.92%	29.62%	-	-	-	-
Buyback Yield / Dilution	-0.73%	-0.61%	-0.97%	-7.06%	-5.21%	5.04%
Total Shareholder Return	-0.06%	0.12%	-0.03%	-7.06%	-5.21%	5.04%

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.